Rocket Lab Bull-Case Target $293 Sparks Debate
Morgan Stanley elevates Rocket Lab's bull-case to $293, underscoring potential upside even as the stock retreats in a...
Investors use market indices for benchmarking, asset allocation, and risk management, enabling efficient, cost-effective exposure to markets.
27,738 articlesMorgan Stanley elevates Rocket Lab's bull-case to $293, underscoring potential upside even as the stock retreats in a...
An executive’s $3.6 million share sale can spark questions for investors. This comprehensive guide explains what the ...
Lucid has wowed investors with fast-paced progress and bold promises. Yet the stock faces real headwinds. Here are th...
A disciplined approach using SPYI could deliver about $100 in monthly cash from a $10,000 investment, driven by optio...
Two power players, two paths: Constellation Energy and Vistra offer differing mixes of stability and upside. This gui...
Two big drivers could push Truist stock higher in 2026: cheaper funding and faster loan growth. This article breaks d...
A shifting geopolitical landscape intersects AI, policy, and crypto. This article breaks down what Anthropic's used I...
Retirees are swapping stock-heavy plans for dependable income from bonds, while younger generations face higher housi...
Walmart beat Q4 estimates on earnings and revenue but guided FY27 growth below consensus, sparking bearish chatter fr...
A payments stock down draws 30% on growth concerns while a small investor places a $6 million bet as revenue hits $4 ...
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Markets wobble as recession risks rise. This guide explains what it means for your investments and shares concrete st...